Valens Molecules Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.
One of their notable products is SULFASALAZINE USP, with a corresponding US DMF Number 26127.
Remarkably, this DMF maintains an Active status since its submission on June 05, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 08, 2021, and payment made on August 27, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II